Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled time : 07:00 save search
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
Published: 2023-12-26 (Crawled : 07:00) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 54.84%
H: 0.0%
C: 0.0%
biotechnologies cell acquired therapy
Analyses of Kite’s Yescarta® CAR T-Cell Therapy Support Curative Potential in Patients With Non-Hodgkin Lymphomas
Published: 2023-12-12 (Crawled : 07:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: 0.86%
H: 0.49%
C: 0.05%
yescarta t-cell lymphomas potential therapy
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
Published: 2023-09-25 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
altuviiio japan approved therapy
Photodynamic Therapy Market to Amplify Substantially by 2029- Brandessence Market Research
Published: 2023-09-21 (Crawled : 07:00) - prnewswire.com
BFAGY | $2.48
|
n/a
| Email alert
Add to watchlist
BFFTF | $1.08 0% 400
|
n/a
| Email alert
Add to watchlist
research therapy market
Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III – Yahoo Finance
Published: 2023-08-10 (Crawled : 07:00) - spacfeed.com
VCXB | $10.86 -0.09% 0.0% 4.6K
|
|
| O: 0.19%
H: 0.0%
C: -0.01%
VCXA 4 | $6.5565 -12.61% 63.5% 0
|
|
| O: 0.0%
H: 0.39%
C: 0.39%
business acquisition therapy
Image guided therapy system market to grow by USD 1,594.18 million between 2022 to 2027|Growth opportunities led by Brainlab AG, and C RAD AB - Technavio
Published: 2023-07-31 (Crawled : 07:00) - prnewswire.com
CAJPY | $27.66 -3.72% -0.41% 60K
|
n/a
|
| O: 0.57%
H: 0.14%
C: -0.06%
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: -0.99%
ABT | News | $106.89 -0.65% 0.07% 4.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
system therapy market
Gilteritinib as Maintenance Therapy Demonstrated Benefit in Subgroups of FLT3-ITD Acute Myeloid Leukemia Patients
Published: 2023-06-09 (Crawled : 07:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 21K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
ALPMY | News | $9.47 -0.21% -1.11% 400K
|
Manufacturing
|
| O: 0.81%
H: 0.0%
C: -0.06%
leukemia therapy
BioWorld by Clarivate Explores the New Era of Radiopharmaceuticals and its Emergence as a Novel Cancer Therapy
Published: 2023-04-13 (Crawled : 07:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.25%
H: 0.51%
C: 0.51%
CLVT | $7.11 -0.42% 0.0% 2.1M
|
Information
|
| O: 0.89%
H: 2.54%
C: 1.87%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 1.3%
H: 0.56%
C: 0.51%
cancer therapy
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
Published: 2023-04-03 (Crawled : 07:00) - biospace.com/
RLFTF | $1.45 11.45% 390
|
n/a
|
| O: -0.44%
H: 10.62%
C: 1.77%
therapeutics therapy
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy
Published: 2023-03-16 (Crawled : 07:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
illuccix fda therapy
FDA approves once-weekly efanesoctocog alfa, a new class of high-sustained factor VIII therapy for haemophilia A: Swedish Orphan Biovitrum AB
Published: 2023-02-24 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -2.11%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
fda haemophilia therapy
Benign Prostatic Hyperplasia (BPH) Devices Market to Grow by USD 3.34 Bn, TURP to be Largest Revenue-generating Therapy Segment - Technavio
Published: 2022-11-01 (Crawled : 07:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 21K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -1.67%
PRCT A | $52.48 -2.36% -2.36% 520K
|
Manufacturing
|
| O: 0.97%
H: 1.4%
C: 0.48%
ALPMY | News | $9.47 -0.21% -1.11% 400K
|
Manufacturing
|
| O: 1.1%
H: 0.41%
C: 0.27%
therapy market
Breast Cancer Therapeutics Market Size to Grow by USD 13.85 Bn, Targeted Therapy to be Largest Revenue-generating Product Segment - Technavio
Published: 2022-10-27 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 1.47%
H: 0.21%
C: -0.7%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: 0.1%
H: 0.85%
C: -1.1%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.06%
H: 0.44%
C: -0.15%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.12%
H: 0.47%
C: 0.21%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.82%
H: 0.15%
C: -0.17%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
PBYI | $4.83 -5.85% -5.99% 370K
|
Health Technology
|
| O: 1.32%
H: 0.43%
C: -3.46%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: -0.48%
H: 0.56%
C: -0.12%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 0.5%
H: 0.49%
C: -0.29%
breast therapeutics therapy cancer market
ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System
Published: 2022-09-23 (Crawled : 07:00) - globenewswire.com
CLPT | $5.32 -3.27% -3.19% 59K
|
Health Technology
|
| O: 0.89%
H: 6.08%
C: 4.12%
fda clearance system laser therapy
MeiraGTx’s Industry-Leading Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Head of Irish Government
Published: 2022-09-16 (Crawled : 07:00) - globenewswire.com
MGTX | $4.86 -1.42% -1.23% 110K
|
Health Technology
|
| O: -2.22%
H: 2.83%
C: 2.15%
therapy
Exelixis and BioInvent Establish Exclusive Option and License Agreement to Develop Novel Antibody-Based Immuno-Oncology Therapies
Published: 2022-06-16 (Crawled : 07:00) - biospace.com/
EXEL | $23.71 1.8% 1.73% 1.6M
|
Health Technology
|
| O: -0.45%
H: 1.02%
C: -0.34%
license therapy
Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
Published: 2022-05-24 (Crawled : 07:00) - prnewswire.com
ILMN | $122.87 -1.28% -1.4% 720K
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: -1.23%
rare diagnostic genetic therapy
European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B
Published: 2022-03-28 (Crawled : 07:00) - prnewswire.com
QURE | $4.56 -4.0% -3.94% 640K
|
Health Technology
|
| O: 0.89%
H: 1.42%
C: -2.9%
therapy
ObsEva Announces Additional Efficacy Results for Linzagolix 200 mg with Add-Back Therapy (ABT) and Linzagolix 75 mg without ABT in the Phase 3 EDELWEISS 3 Trial in Patients with Moderate-to-Severe Endometriosis-Associated Pain
Published: 2022-03-22 (Crawled : 07:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: -1.63%
H: 9.09%
C: 9.09%
trial therapy linzagolix results phase 3
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 31.15%
H: 19.58%
C: 9.17%
trace novartis aav capsids gene therapy program license therapeutics therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.